SAB Biotherapeutics
SABS
SABS
24 hedge funds and large institutions have $15.2M invested in SAB Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
86% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 21
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$348K | |
| 2 | +$245K | |
| 3 | +$126K | |
| 4 |
BlackRock
New York
|
+$4.88K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.91K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$555K | |
| 3 | -$60.5K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$55.9K |
| 5 |
Mariner
Overland Park,
Kansas
|
-$47.4K |